Ashwagandha
- Generic Name
- Ashwagandha
Combination Therapy for Recurrent Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Recurrent Ovarian Cancer
- Interventions
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Sham Sunder Kakar
- Target Recruit Count
- 72
- Registration Number
- NCT05610735
- Locations
- 🇺🇸
UofL Health Brown Cancer Center, Louisville, Kentucky, United States
Ashwagandha for Cognitive Dysfunction
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Sutter Health
- Target Recruit Count
- 80
- Registration Number
- NCT04092647
- Locations
- 🇺🇸
Sutter Cancer Center, Sacramento, California, United States
Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis
- First Posted Date
- 2018-05-23
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Tatyasaheb Kore Dental College
- Target Recruit Count
- 50
- Registration Number
- NCT03533972
- Locations
- 🇮🇳
Tatyasaheb Kore Dental College, Kolhapur, Maharashtra, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath